ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SXTPW 60 Degrees Pharmaceuticals Inc

0.0206
0.00 (0.00%)
Pre Market
Last Updated: 18:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.0205
Ask Price 0.0395
News -
Share Name Share Symbol Market Stock Type
60 Degrees Pharmaceuticals Inc SXTPW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0206 18:00:00
Open Price Low Price High Price Close Price Previous Close
0.0206
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0  0.0206 USD

60 Degrees Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
119.48k 5.80M - 254k -3.77M -0.65 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News 60 Degrees Pharmaceuticals

Date Time Source Heading
2/06/202515:41Edgar (US Regulatory)Form 8-K - Current report
2/06/202513:07GlobeNewswire Inc.60 Degrees Pharma Announces Closing of $1.075 Million..
2/06/202509:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/05/202508:22GlobeNewswire Inc.60 Degrees Pharma Announces $1.075 Million Registered Direct..
1/30/202516:30Edgar (US Regulatory)Form 8-K - Current report
1/30/202513:20GlobeNewswire Inc.60 Degrees Pharma Announces Closing of $1.043 Million..
1/30/202507:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
1/29/202507:00GlobeNewswire Inc.60 Degrees Pharma Announces $1.043 Million Registered Direct..
1/28/202515:05Edgar (US Regulatory)Form 8-K - Current report
1/28/202507:01GlobeNewswire Inc.60 Degrees Pharma Announces IRB Approval of Phase II Study..
1/24/202515:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/24/202515:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SXTPW Message Board. Create One! See More Posts on SXTPW Message Board See More Message Board Posts

SXTPW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older. The Company's pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases; new products that contain the Arakoda regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. The ARAKODA regimen of tafenoquine is in Phase II study data in patients with mild-moderate COVID-19 disease. It is also planning a clinical study to assess the utility of ARAKODA as a treatment for human babesiosis. The Company is also developing Celgosivir for the treatment of COVID-19, respiratory syncytial virus (RSV), and dengue.

NASDAQ:SXTPW -

What is the current 60 Degrees Pharmaceuticals Inc share price?
The current share price of 60 Degrees Pharmaceuticals Inc is US$ 0.0206
How many 60 Degrees Pharmaceuticals Inc shares are in issue?
60 Degrees Pharmaceuticals Inc has 5,800,000 shares in issue
What is the market cap of 60 Degrees Pharmaceuticals Inc?
The market capitalisation of 60 Degrees Pharmaceuticals Inc is USD 119.48k
What is the 1 year trading range for 60 Degrees Pharmaceuticals Inc share price?
60 Degrees Pharmaceuticals Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of 60 Degrees Pharmaceuticals Inc?
The price to earnings ratio of 60 Degrees Pharmaceuticals Inc is -0.82
What is the cash to sales ratio of 60 Degrees Pharmaceuticals Inc?
The cash to sales ratio of 60 Degrees Pharmaceuticals Inc is 12.1
What is the reporting currency for 60 Degrees Pharmaceuticals Inc?
60 Degrees Pharmaceuticals Inc reports financial results in USD
What is the latest annual turnover for 60 Degrees Pharmaceuticals Inc?
The latest annual turnover of 60 Degrees Pharmaceuticals Inc is USD 254k
What is the latest annual profit for 60 Degrees Pharmaceuticals Inc?
The latest annual profit of 60 Degrees Pharmaceuticals Inc is USD -3.77M
What is the registered address of 60 Degrees Pharmaceuticals Inc?
The registered address for 60 Degrees Pharmaceuticals Inc is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the 60 Degrees Pharmaceuticals Inc website address?
The website address for 60 Degrees Pharmaceuticals Inc is 60degreespharma.com
Which industry sector does 60 Degrees Pharmaceuticals Inc operate in?
60 Degrees Pharmaceuticals Inc operates in the PHARMACEUTICAL PREPARATIONS sector

Your Recent History

Delayed Upgrade Clock